Loading...
(18)F-Fludeoxyglucose PET/CT in SCLC: Analysis of the CONVERT Randomized Controlled Trial
INTRODUCTION: We used phase-3 CONVERT trial data to investigate the impact of fludeoxyglucose F 18 ((18)F-FDG) positron emission tomography (PET)/computed tomography (CT) in SCLC. METHODS: CONVERT randomized patients with limited-stage SCLC to twice-daily (45 Gy in 30 fractions) or once-daily (66 Gy...
Na minha lista:
| Udgivet i: | J Thorac Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6616906/ https://ncbi.nlm.nih.gov/pubmed/31002954 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2019.03.023 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|